Innovative Medicines Canada responds to release of Patented Medicine Prices Review Board’s (PMPRB) final Guidelines
STATEMENT Ottawa, October 23, 2020 – Innovative Medicines Canada (IMC) issued the following statement today in response to the release of […]


